Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Int Braz J Urol ; 41(4): 623-34, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26401853

RESUMO

The use of meshes has become the first option for the treatment of soft tissue disorders as hernias and stress urinary incontinence and widely used in vaginal prolapse's treatment. However, complications related to mesh issues cannot be neglected. Various strategies have been used to improve tissue integration of prosthetic meshes and reduce related complications. The aim of this review is to present the state of art of mesh innovations, presenting the whole arsenal which has been studied worldwide since composite meshes, coated meshes, collagen's derived meshes and tissue engineered prostheses, with focus on its biocompatibility and technical innovations, especially for vaginal prolapse surgery.


Assuntos
Materiais Revestidos Biocompatíveis/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Telas Cirúrgicas , Prolapso Uterino/cirurgia , Implantes Absorvíveis , Feminino , Humanos , Invenções , Engenharia Tecidual/métodos
2.
Int. braz. j. urol ; 41(4): 623-634, July-Aug. 2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-763049

RESUMO

ABSTRACTThe use of meshes has become the first option for the treatment of soft tissue disorders as hernias and stress urinary incontinence and widely used in vaginal prolapse's treatment. However, complications related to mesh issues cannot be neglected. Various strategies have been used to improve tissue integration of prosthetic meshes and reduce related complications. The aim of this review is to present the state of art of mesh innovations, presenting the whole arsenal which has been studied worldwide since composite meshes, coated meshes, collagen's derived meshes and tissue engineered prostheses, with focus on its biocompatibility and technical innovations, especially for vaginal prolapse surgery.


Assuntos
Feminino , Humanos , Materiais Revestidos Biocompatíveis/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Telas Cirúrgicas , Prolapso Uterino/cirurgia , Implantes Absorvíveis , Invenções , Engenharia Tecidual/métodos
3.
Acta Cir Bras ; 30(2): 127-33, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25714692

RESUMO

PURPOSE: To evaluate renal histological changes and renal function in single kidney rats submitted to renal ischemia-reperfusion and to immunosuppression with tacrolimus and mycophenolate-mofetil. METHODS: Experimental study with 80 Wistar rats distributed into control, Sham and six other groups treated with immunosuppressive drugs. Animals undergoing surgery, right nephrectomy and left renal clamping, killed on the 14th day and analyzed for renal histology, urea and creatinine. RESULTS: The group receiving tacrolimus at higher doses (T3) showed renal histological lesions indicative of early nephrotoxicity, and significant increase in urea and creatinine. The group M (mycophenolate-mofetil alone) and the group M2 (mycophenolate-mofetil combined with half the usual dose of tacrolimus) presented a slight rise in serum urea. The groups using mycophenolate-mofetil alone or combined with tacrolimus showed creatinine levels similar to that of the group T3. CONCLUSIONS: Histologically, the association of injury by ischemia-reperfusion with the use of tacrolimus or mycophenolate-mofetil alone demonstrated a higher rate of renal changes typical of early nephrotoxicity. In laboratory, the combination of injury by ischemia-reperfusion with tacrolimus at higher doses proved to be nephrotoxic.


Assuntos
Imunossupressores/efeitos adversos , Isquemia/complicações , Nefropatias/etiologia , Rim/irrigação sanguínea , Ácido Micofenólico/análogos & derivados , Traumatismo por Reperfusão/complicações , Tacrolimo/efeitos adversos , Animais , Inibidores de Calcineurina/efeitos adversos , Creatinina/sangue , Terapia de Imunossupressão/efeitos adversos , Imunossupressores/sangue , Rim/patologia , Nefropatias/patologia , Nefropatias/fisiopatologia , Masculino , Ácido Micofenólico/efeitos adversos , Néfrons/efeitos dos fármacos , Distribuição Aleatória , Ratos Wistar , Tacrolimo/sangue , Fatores de Tempo , Ureia/sangue
4.
Acta cir. bras ; 30(2): 127-133, 02/2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-741031

RESUMO

PURPOSE: To evaluate renal histological changes and renal function in single kidney rats submitted to renal ischemia-reperfusion and to immunosuppression with tacrolimus and mycophenolate-mofetil. METHODS: Experimental study with 80 Wistar rats distributed into control, Sham and six other groups treated with immunosuppressive drugs. Animals undergoing surgery, right nephrectomy and left renal clamping, killed on the 14th day and analyzed for renal histology, urea and creatinine. RESULTS: The group receiving tacrolimus at higher doses (T3) showed renal histological lesions indicative of early nephrotoxicity, and significant increase in urea and creatinine. The group M (mycophenolate-mofetil alone) and the group M2 (mycophenolate-mofetil combined with half the usual dose of tacrolimus) presented a slight rise in serum urea. The groups using mycophenolate-mofetil alone or combined with tacrolimus showed creatinine levels similar to that of the group T3. CONCLUSIONS: Histologically, the association of injury by ischemia-reperfusion with the use of tacrolimus or mycophenolate-mofetil alone demonstrated a higher rate of renal changes typical of early nephrotoxicity. In laboratory, the combination of injury by ischemia-reperfusion with tacrolimus at higher doses proved to be nephrotoxic. .


Assuntos
Animais , Masculino , Imunossupressores/efeitos adversos , Isquemia/complicações , Nefropatias/etiologia , Rim/irrigação sanguínea , Ácido Micofenólico/análogos & derivados , Traumatismo por Reperfusão/complicações , Tacrolimo/efeitos adversos , Inibidores de Calcineurina/efeitos adversos , Creatinina/sangue , Terapia de Imunossupressão/efeitos adversos , Imunossupressores/sangue , Nefropatias/patologia , Nefropatias/fisiopatologia , Rim/patologia , Ácido Micofenólico/efeitos adversos , Néfrons/efeitos dos fármacos , Distribuição Aleatória , Ratos Wistar , Fatores de Tempo , Tacrolimo/sangue , Ureia/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...